This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cognex Corporation (CGNX) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognex (CGNX) delivered earnings and revenue surprises of 15% and 2.44%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ametek (AME) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ametek (AME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teradyne (TER) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Teradyne (TER) delivered earnings and revenue surprises of 13.16% and 3.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Cognex Corporation (CGNX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cognex (CGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Cognex (CGNX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cognex (CGNX) stock based on the movements in the options market lately.
Itron (ITRI) Stock Jumps 3.4%: Will It Continue to Soar?
by Zacks Equity Research
Itron (ITRI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Is ProShares S&P Technology Dividend Aristocrats ETF (TDV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for TDV
Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHSC
Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHSC
Cognex Corporation (CGNX) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex (CGNX) delivered earnings and revenue surprises of 37.50% and 6.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cognex Corporation (CGNX) Matches Q4 Earnings Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 0% and 4.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognex Corporation (CGNX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 6.67% and 3.65%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Itron (ITRI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Itron (ITRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Cognex Corporation (CGNX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cognex Corporation (CGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cognex Corporation (CGNX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 28% and 4.99%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Fortive (FTV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Fortive (FTV) delivered earnings and revenue surprises of 4.94% and 1.68%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Cognex (CGNX) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cognex (CGNX) stock based on the movements in the options market lately.
Cognex Corporation (CGNX) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 44.44% and 3.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ametek (AME) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Ametek (AME) delivered earnings and revenue surprises of 5.67% and 4.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 7th
by Zacks Equity Research
CGNX, BFAM and AVY have been added to the Zacks Rank #5 (Strong Sell) List on March 7, 2023.
Cognex Corporation (CGNX) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of -12.90% and 0.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Teradyne (TER) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Teradyne (TER) delivered earnings and revenue surprises of 24.32% and 3.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cognex Corporation (CGNX) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Cognex Corporation (CGNX) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 75% and 6.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Healthy Revenue Growth Aid Axcelis' (ACLS) Q3 Earnings?
by Zacks Equity Research
Axcelis (ACLS) is expected to have recorded year-over-year higher revenues on the back of healthy demand trends.